The second edition of Boston/Paris Biotechnology Summit – titled From the Promise of Raising Capital to the Reality of Clinical Trials - is taking place in Boston, on Sunday June 3, 2018, just prior to this year’ BIO-2018.

Genopole is sponsoring the 2018 Summit and is on the Expert Advisory Group.

Although this event is especially designed for French entrepreneurs, it is open to all.

The programme includes 25 expert speakers who are acclaimed biotechnology leaders – e.g., David Meek, CEO of IPSEN ; Dr. Robert Urban, Global Head of Innovation at Johnson & Johnson ; Dr. Mark Murcko, record-holder with 7 drugs developed and taken to Market ; Professor Kenneth Kaitin, of Tufts’ Center for Study of Drug Development ; Dr. Joseph Merola, Director of Clinical Trials at Harvard Medical School, Veleka Peeples-Dyer, Co-Leader of FDA Practice at MWE in Boston).

The Summit provides excellent international networking opportunities as participants come from over 100 biotechnology organizations and also include Boston-based investors in life sciences.

BOSTON-PARIS BIOTECHNOLOGY SUMMIT 2018

For more information and registration details, please see : http://www.bostonbiotechnologysummit.com/

Place :

Exchange Conference Center
Fish Pier
212 Northern Ave
Boston, MA 02210